Dispersyn Gerrit 4
4 · Phio Pharmaceuticals Corp. · Filed Aug 2, 2019
Insider Transaction Report
Form 4
Dispersyn Gerrit
Chief Development Officer
Transactions
- Tax Payment
Common stock, $0.0001 par value
2019-08-01$0.40/sh−1,236$498→ 477,817 total
Footnotes (2)
- [F1]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]Includes shares of common stock underlying unvested restricted stock units.